Nanjing Pharmaceutical Group Company Limited (SHA:600713)
China flag China · Delayed Price · Currency is CNY
6.40
+0.43 (7.20%)
Apr 15, 2026, 3:00 PM CST

SHA:600713 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8,3777,1476,4946,3426,7095,114
Market Cap Growth
26.69%10.05%2.41%-5.47%31.18%10.34%
Enterprise Value
11,73918,87317,41518,81816,76614,628
Last Close Price
6.405.464.804.514.654.35
PE Ratio
15.0211.4411.3810.9811.2610.12
Forward PE
-27.4227.4227.4227.4227.42
PS Ratio
0.150.130.120.120.130.11
PB Ratio
1.020.870.830.871.000.98
P/TBV Ratio
1.211.030.991.031.181.20
P/FCF Ratio
--4.083.63-13.15
P/OCF Ratio
91.2477.843.043.33-7.36
EV/Sales Ratio
0.210.340.320.350.330.32
EV/EBITDA Ratio
7.2412.4710.4111.3810.8710.10
EV/EBIT Ratio
8.7114.0011.3312.5512.0711.25
EV/FCF Ratio
-73.57-10.9510.76-37.63
Debt / Equity Ratio
0.670.671.311.261.831.89
Debt / EBITDA Ratio
3.433.435.705.157.416.40
Debt / FCF Ratio
--6.415.21-25.38
Net Debt / Equity Ratio
0.280.280.720.931.481.49
Net Debt / EBITDA Ratio
1.521.523.374.086.415.37
Net Debt / FCF Ratio
-14.38-14.383.543.85-11.8119.99
Asset Turnover
1.771.771.821.791.751.83
Inventory Turnover
7.827.828.338.689.129.83
Quick Ratio
1.101.101.161.000.970.99
Current Ratio
1.531.531.631.401.311.34
Return on Equity (ROE)
10.38%10.38%9.88%10.22%12.00%12.15%
Return on Assets (ROA)
2.71%2.71%3.25%3.12%3.02%3.30%
Return on Invested Capital (ROIC)
6.63%8.09%8.31%7.15%7.42%7.57%
Return on Capital Employed (ROCE)
10.40%10.40%11.30%15.20%14.80%15.60%
Earnings Yield
7.46%8.74%8.79%9.11%8.88%9.88%
FCF Yield
-1.90%-2.23%24.50%27.57%-12.48%7.60%
Dividend Yield
2.85%-3.54%3.55%3.01%2.76%
Payout Ratio
98.84%98.84%88.47%101.75%81.07%185.06%
Buyback Yield / Dilution
-12.58%-12.58%-0.33%-3.54%-20.39%0.10%
Total Shareholder Return
-9.68%-12.58%3.21%0.00%-17.39%2.86%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.